June 21, 2022

Ultima Genomics, Exact Sciences In Deal To Improve Patient Access To Genomics-based Testing

(RTTNews) – Ultima Genomics, Inc. and Exact Sciences Corporation (EXAS) have inked a long-term supply deal through which Exact Sciences will receive Ultima’s next-generation sequencing or NGS technologies to reduce the high cost of sequencing and to support patient access to geno

This post was originally published on this site

Sign Up To Get FREE News, Tips and Offers!

X